Jerome E. Groopman

25.6k total citations · 10 hit papers
212 papers, 20.3k citations indexed

About

Jerome E. Groopman is a scholar working on Immunology, Oncology and Virology. According to data from OpenAlex, Jerome E. Groopman has authored 212 papers receiving a total of 20.3k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Immunology, 53 papers in Oncology and 49 papers in Virology. Recurrent topics in Jerome E. Groopman's work include HIV Research and Treatment (49 papers), Immune Cell Function and Interaction (33 papers) and T-cell and Retrovirus Studies (29 papers). Jerome E. Groopman is often cited by papers focused on HIV Research and Treatment (49 papers), Immune Cell Function and Interaction (33 papers) and T-cell and Retrovirus Studies (29 papers). Jerome E. Groopman collaborates with scholars based in United States, Israel and Canada. Jerome E. Groopman's co-authors include Ramesh K. Ganju, Randal A. Byrn, Pamela Hartzband, Margaret A. Fischl, Michael S. Gottlieb, Paul A. Volberding, Donna Mildvan, George Gee Jackson, Oscar L. Laskin and Douglas D. Richman and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jerome E. Groopman

205 papers receiving 19.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

1987 2.3k citations Michael S. Gottlieb, Jerome E. Groopman et al. New England Journal of Medicine profile →
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

2000 979 citations Jerome E. Groopman et al. profile →
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

1987 975 citations Michael S. Gottlieb, Jerome E. Groopman et al. New England Journal of Medicine profile →
Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome

1985 836 citations J. Davis Allan, Jerome E. Groopman et al. New England Journal of Medicine profile →
HTLV-III Infection in Brains of Children and Adults with AIDS Encephalopathy

1985 739 citations Jerome E. Groopman et al. profile →
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.

1997 625 citations Jerome E. Groopman et al. PubMed profile →
The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways

1998 543 citations Ramesh K. Ganju, Jerome E. Groopman et al. profile →
Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

1984 531 citations Jerome E. Groopman et al. profile →
Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome

1987 512 citations Jerome E. Groopman et al. New England Journal of Medicine profile →
Designing CD4 immunoadhesins for AIDS therapy

1989 508 citations Randal A. Byrn, Jerome E. Groopman et al. profile →

Peers

Countries citing papers authored by Jerome E. Groopman

Since Specialization

Citations

This map shows the geographic impact of Jerome E. Groopman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome E. Groopman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome E. Groopman more than expected).

Fields of papers citing papers by Jerome E. Groopman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome E. Groopman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome E. Groopman. The network helps show where Jerome E. Groopman may publish in the future.

Co-authorship network of co-authors of Jerome E. Groopman

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome E. Groopman. A scholar is included among the top collaborators of Jerome E. Groopman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome E. Groopman. Jerome E. Groopman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Medical Taylorism 2016 ·New England Journal of Medicine ·Pamela Hartzband, Jerome E. Groopman	51
2	Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma 2012 ·Clinical Cancer Research ·Anil Prasad, Ashutosh Shrivastava, Evangelos Papadopoulos, Paula M. Kuzontkoski, M. V. Ramana Reddy, Amanda M. Gillum, Ramesh Kumar, E. Premkumar Reddy, Jerome E. Groopman	4
3	Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy 2011 ·Molecular Cancer Therapeutics ·Ashutosh Shrivastava, Paula M. Kuzontkoski, Jerome E. Groopman, Anil Prasad	365
4	Untangling the Web — Patients, Doctors, and the Internet 2010 ·New England Journal of Medicine ·Pamela Hartzband, Jerome E. Groopman	98
5	Buying a cure: what business know-how can do for disease. 2008 ·PubMed ·Jerome E. Groopman	2
6	Underlying Pathophysiology of HCV Infection in HIV-Positive Drug Users 2008 ·Journal of Addictive Diseases ·Anuradha Balasubramanian, Jerome E. Groopman, Ramesh K. Ganju	6
7	The right to a trial: Should dying patients have access to experimental drugs? 2006 ·PubMed ·Jerome E. Groopman	5
8	Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma 2002 ·AIDS ·Steven A. Miles, Bruce J. Dezube, Jeannette Y. Lee, Susan E. Krown, Mary A Fletcher, M. Wayne Saville, Lawrence D. Kaplan, Jerome E. Groopman, David T. Scadden, Timothy P. Cooley, Jamie Von Roenn, Alvin E. Friedman‐Kien	42
9	HIV-1 Tat Induces Microvascular Endothelial Apoptosis Through Caspase Activation 2001 ·The Journal of Immunology ·In-Woo Park, Christina Ullrich, (unknown), Ramesh K. Ganju, Jerome E. Groopman	67
10	Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. 2000 ·PubMed ·Madeleine Duvic, Alvin E. Friedman‐Kien, David J. Looney, Steven A. Miles, Patricia L. Myskowski, David T. Scadden, Jamie Von Roenn, Jeffrey E. Galpin, Jerome E. Groopman, Gordon Loewen, Victor J. Stevens, J A Truglia, Richard C. Yocum	46
11	c-Src Mediates Mitogenic Signals and Associates with Cytoskeletal Proteins upon Vascular Endothelial Growth Factor Stimulation in Kaposi’s Sarcoma Cells 2000 ·The Journal of Immunology ·Neru Munshi, Jerome E. Groopman, Parkash S. Gill, Ramesh K. Ganju	38
12	Transfusion in HIV disease 1997 ·Current Opinion in Hematology ·Elaine M. Sloand, Jerome E. Groopman	5
13	Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. 1997 ·Journal of Clinical Investigation ·(unknown), Ramesh K. Ganju, (unknown), (unknown), William C. Hatch, T. Zheng, S Avraham, Parkash S. Gill, Jerome E. Groopman	66
14	Stimulation of Human Immunodeficiency Virus Type 1 Expression by Ceramide 1994 ·AIDS Research and Human Retroviruses ·Béla Papp, (unknown), Jerome E. Groopman, Randal A. Byrn	14
15	The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors 1994 ·AIDS ·Koushi Yamaguchi, Jerome E. Groopman, Randal A. Byrn	32
16	In vitro effects of stem-cell factor or interleukin-3 on myelosuppression associated with AIDS 1994 ·AIDS ·David T. Scadden, Anlai Wang, Krisztina M. Zsebo, Jerome E. Groopman	11
17	Long-Term Follow-Up of Didanosine Administered Orally Twice Daily to Patients with Advanced Human Immunodeficiency Virus Infection and Hematologic Intolerance of Zidovudine 1993 ·Clinical Infectious Diseases ·J. Davis Allan, Kevin Connolly, (unknown), (unknown), C. McLaren, Renzo Canetta, Jerome E. Groopman	19
18	Human retroviruses : proceedings of a Chimertech-UCLA Symposium held at Tamarron, Colorado, February 4-11, 1989 1990 ·Jerome E. Groopman	1
19	Transfusion Associated AIDS 1988 ·Transfusion Medicine Reviews ·(unknown), Jerome E. Groopman	3
20	Acquired immune deficiency syndrome : proceedings of a Schering Corp.-UCLA Symposium held in Park City, Utah, February 5-10, 1984 1984 ·Michael S. Gottlieb, Jerome E. Groopman	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact